Centene Corporation Announces Transition of New Chief Financial Officer
On August 17, 2026, Centene Corporation, a Fortune 500 leader in the healthcare sector, announced significant leadership changes with the planned retirement of its Chief Financial Officer (CFO), Drew Asher. After an impressive tenure that began in 2021, Asher informed the company of his intent to step down from his role at the end of December 2026, ultimately retiring from Centene by the close of 2027. This transition comes as part of Centene's broader strategy to ensure smooth operational continuity while adapting to the evolving healthcare landscape.
Taking over the reins from Asher will be Chris Neczypor, who is set to join Centene in September 2026 and will be officially assuming the role of Executive Vice President and CFO starting January 1, 2027. Neczypor is a seasoned executive whose background in corporate finance spans over a decade, including his previous position as CFO at Lincoln Financial. His extensive experience in financial strategy, capital management, and transformation will be instrumental as Centene continues to grow and adapt during this pivotal transition.
In welcoming Neczypor, Sarah M. London, Centene's CEO, emphasized his track record of enhancing financial performance and fostering operational efficiency. London expressed her enthusiasm about Neczypor's approach to leadership, highlighting his collaborative spirit and values-driven management style, which she feels will greatly benefit Centene during its next phase of growth.
Drew Asher's career in finance and healthcare has spanned over thirty years, during which he has significantly influenced Centene's trajectory. Under his leadership, the company has seen remarkable growth, escalating from approximately $126 billion in revenues in 2021 to around $195 billion by 2025. Asher's tenure was marked by strategic financial stewardship that not only stabilized the company but also positioned it for future success amidst a rapidly evolving market.
Reflecting on his time at Centene, Asher remarked about the proud journey the company undertook through periods of significant change. He noted, "I am incredibly proud of how Centene navigated through unprecedented change while remaining disciplined in execution and focused on long-term value." Asher intends to remain with the company until his retirement to assist in various strategic initiatives and ensure that the transition process is seamless.
Asher's decades-long experience highlighted a persistent focus on value creation and healthcare transformation, which he believes are foundational for Centene's ongoing influence in the healthcare industry. With his departure approaching, he concluded his remarks with confidence in the leadership team and the company’s ability to foster continued innovation and effectiveness in transforming healthcare services.
Moreover, CEO Sarah London took a moment to thank Asher for his invaluable contributions, praising his financial discipline and strategic insights that have laid the groundwork for Centene’s continued success. She affirmed that his presence would still be felt throughout the transition as the company gears up for its next chapter.
As Centene prepares to move into this new phase, the company reaffirms its commitment to its previously communicated guidance for the full year of 2026, targeting adjusted diluted earnings per share exceeding $4.80, along with all associated metrics previously shared in the second quarter earnings report. This announcement is set against the backdrop of Centene's ongoing mission to provide comprehensive healthcare services, focusing on under-insured and uninsured populations through locally driven, affordable, and quality healthcare solutions.
The leadership transition marks an exciting prospect not only for Centene as an organization but also for the communities it serves. With Chris Neczypor stepping into a pivotal role, there are high expectations for innovative approaches to managing financial and operational strategies that will further the company’s mission and its impact on healthcare across America.
Taking over the reins from Asher will be Chris Neczypor, who is set to join Centene in September 2026 and will be officially assuming the role of Executive Vice President and CFO starting January 1, 2027. Neczypor is a seasoned executive whose background in corporate finance spans over a decade, including his previous position as CFO at Lincoln Financial. His extensive experience in financial strategy, capital management, and transformation will be instrumental as Centene continues to grow and adapt during this pivotal transition.
In welcoming Neczypor, Sarah M. London, Centene's CEO, emphasized his track record of enhancing financial performance and fostering operational efficiency. London expressed her enthusiasm about Neczypor's approach to leadership, highlighting his collaborative spirit and values-driven management style, which she feels will greatly benefit Centene during its next phase of growth.
Drew Asher's career in finance and healthcare has spanned over thirty years, during which he has significantly influenced Centene's trajectory. Under his leadership, the company has seen remarkable growth, escalating from approximately $126 billion in revenues in 2021 to around $195 billion by 2025. Asher's tenure was marked by strategic financial stewardship that not only stabilized the company but also positioned it for future success amidst a rapidly evolving market.
Reflecting on his time at Centene, Asher remarked about the proud journey the company undertook through periods of significant change. He noted, "I am incredibly proud of how Centene navigated through unprecedented change while remaining disciplined in execution and focused on long-term value." Asher intends to remain with the company until his retirement to assist in various strategic initiatives and ensure that the transition process is seamless.
Asher's decades-long experience highlighted a persistent focus on value creation and healthcare transformation, which he believes are foundational for Centene's ongoing influence in the healthcare industry. With his departure approaching, he concluded his remarks with confidence in the leadership team and the company’s ability to foster continued innovation and effectiveness in transforming healthcare services.
Moreover, CEO Sarah London took a moment to thank Asher for his invaluable contributions, praising his financial discipline and strategic insights that have laid the groundwork for Centene’s continued success. She affirmed that his presence would still be felt throughout the transition as the company gears up for its next chapter.
As Centene prepares to move into this new phase, the company reaffirms its commitment to its previously communicated guidance for the full year of 2026, targeting adjusted diluted earnings per share exceeding $4.80, along with all associated metrics previously shared in the second quarter earnings report. This announcement is set against the backdrop of Centene's ongoing mission to provide comprehensive healthcare services, focusing on under-insured and uninsured populations through locally driven, affordable, and quality healthcare solutions.
The leadership transition marks an exciting prospect not only for Centene as an organization but also for the communities it serves. With Chris Neczypor stepping into a pivotal role, there are high expectations for innovative approaches to managing financial and operational strategies that will further the company’s mission and its impact on healthcare across America.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.